Publications

Found 169 results
Filters: Filter is   [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
H
Haigh DB, Woodcock CL, Lothion-Roy J, Harris AE, Metzler VM, Persson JL, Robinson BD, Khani F, Alsaleem M, Ntekim A et al..  2022.  The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer.. Cancers (Basel). 14(20)
G
Gudas LJ.  2013.  Retinoids induce stem cell differentiation via epigenetic changes.. Semin Cell Dev Biol. 24(10-12):701-5.
Gudas LJ.  2022.  Retinoid metabolism: new insights.. J Mol Endocrinol.
Gudas LJ.  2012.  Emerging roles for retinoids in regeneration and differentiation in normal and disease states.. Biochim Biophys Acta. 1821(1):213-21.
Gudas R, Rimkūnas A, Staškūnas M.  2021.  Large-Diameter Anterior Cruciate Ligament Reconstruction Technique With 8-Strand Semitendinosus and Gracilis Graft.. Arthrosc Tech. 10(4):e981-e986.
Gudas LJ.  2006.  Stem cells, differentiation and cancer: mentors, colleagues and academic administration.. Cancer Biol Ther. 5(9):1244-6.
Gudas LJ.  2022.  Synthetic Retinoids Beyond Cancer Therapy.. Annu Rev Pharmacol Toxicol. 62:155-175.
Gudas LJ, Fu L, Minton DR, Mongan NP, Nanus DM.  2014.  The role of HIF1α in renal cell carcinoma tumorigenesis.. J Mol Med (Berl). 92(8):825-36.
Gudas LJ, Wagner JA.  2011.  Retinoids regulate stem cell differentiation.. J Cell Physiol. 226(2):322-30.
Goldberg JS, Vargas M, Rosmarin AS, Milowsky MI, Papanicoloau N, Gudas LJ, Shelton G, Feit K, Petrylak D, Nanus DM.  2002.  Phase I trial of interferon alpha2b and liposome-encapsulated all-trans retinoic acid in the treatment of patients with advanced renal cell carcinoma.. Cancer. 95(6):1220-7.
Gillespie RF, Gudas LJ.  2007.  Retinoic acid receptor isotype specificity in F9 teratocarcinoma stem cells results from the differential recruitment of coregulators to retinoic response elements.. J Biol Chem. 282(46):33421-34.
Gillespie RF, Gudas LJ.  2007.  Retinoid regulated association of transcriptional co-regulators and the polycomb group protein SUZ12 with the retinoic acid response elements of Hoxa1, RARbeta(2), and Cyp26A1 in F9 embryonal carcinoma cells.. J Mol Biol. 372(2):298-316.
F
Fu L, Wang G, Shevchuk MM, Nanus DM, Gudas LJ.  2013.  Activation of HIF2α in kidney proximal tubule cells causes abnormal glycogen deposition but not tumorigenesis.. Cancer Res. 73(9):2916-25.
Fu L, Minton DR, Zhang T, Nanus DM, Gudas LJ.  2015.  Genome-Wide Profiling of TRACK Kidneys Shows Similarity to the Human ccRCC Transcriptome.. Mol Cancer Res. 13(5):870-8.
Fu L, Wang G, Shevchuk MM, Nanus DM, Gudas LJ.  2011.  Generation of a mouse model of Von Hippel-Lindau kidney disease leading to renal cancers by expression of a constitutively active mutant of HIF1α.. Cancer Res. 71(21):6848-56.
Fernandez CC, Gudas LJ.  2009.  The truncated Hoxa1 protein interacts with Hoxa1 and Pbx1 in stem cells.. J Cell Biochem. 106(3):427-43.
D
DiKun KM, Tang X-H, Fu L, Choi ME, Lu C, Gudas LJ.  2024.  Retinoic acid receptor α activity in proximal tubules prevents kidney injury and fibrosis.. Proc Natl Acad Sci U S A. 121(7):e2311803121.
DiKun KM, Gudas LJ.  2023.  Vitamin A and retinoid signaling in the kidneys.. Pharmacol Ther. 248:108481.
Del Aguila EMere, Tang X-H, Gudas LJ.  2022.  Pancreatic Ductal Adenocarcinoma: New Insights into the Actions of Vitamin A.. Oncol Res Treat.
Del Aguila EMere, Tang X-H, Gudas LJ.  2025.  Retinoic acid receptor-β deletion in a model of early pancreatic ductal adenocarcinoma (PDAC) tumorigenesis.. Am J Cancer Res. 15(1):127-140.
David KA, Mongan NP, Smith C, Gudas LJ, Nanus DM.  2010.  Phase I trial of ATRA-IV and Depakote in patients with advanced solid tumor malignancies.. Cancer Biol Ther. 9(9):678-84.
C
Costet P, Lalanne F, Gerbod-Giannone MC, Molina JR, Fu X, Lund EG, Gudas LJ, Tall AR.  2003.  Retinoic acid receptor-mediated induction of ABCA1 in macrophages.. Mol Cell Biol. 23(21):7756-66.
Chi Y, Chen Q, Del Aguila EMere, Gross SS, Wagner JA, Reilly SM, Nanus DM, Gudas LJ.  2026.  Transcription Factor ATF4 Deletion Reprograms Glucose Metabolism in Clear Cell Renal Cell Carcinoma.. Cancers (Basel). 18(12)
Chi Y, Del Aguila EMere, Zhang T, Warren CD, Hoxie HR, Chen Q, Gross SS, Geri JB, Nanus DM, Gudas LJ.  2025.  ATF4 in proximal tubules modulates kidney function and modifies the metabolome.. J Mol Med (Berl).
Chi Y, Chikara S, Del Aguila EMere, Zhang T, Geri JB, Nanus DM, Gudas LJ.  2025.  Deletion of the transcription factor ATF4 in a model of clear cell renal cell carcinoma.. Neoplasia. 66:101188.